Parame, Erlinda .
HRN: 24-05-37 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2023
AMPICILLIN 1GM (VIAL)
11/12/2023
11/18/2023
IV
2g
Q6
PROM
Checking Final Appropriateness
11/13/2023
CO-AMOXICLAV 625MG (TAB)
11/13/2023
11/20/2023
PO
625 Mg
BID
TMSAF
Checking Final Appropriateness